Quick Answer
Eloxx Pharmaceuticals, Inc. reported Shares Outstanding of 4.79 million shares for fiscal year 2025.
Eloxx Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 4.79M | +35.5% |
| 2024 | 3.53M | +12.4% |
| 2023 | 3.14M | +45.1% |
| 2022 | 2.17M | +0.0% |
| 2021 | 2.17M | -94.6% |
| 2020 | 40.16M | +0.3% |
| 2019 | 40.03M | +11.6% |
| 2018 | 35.86M | +30.3% |
| 2017 | 27.53M | -5.7% |
| 2017 | 29.20M | +594.4% |
| 2016 | 4.21M | -79.5% |
| 2016 | 20.50M | +9.3% |
| 2015 | 18.75M | +35.4% |
| 2014 | 13.85M | +509.4% |
| 2013 | 2.27M | -97.6% |
| 2012 | 94.11M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | 2.17M | -97.5% | +0.0% |
| June 30, 2023 | 2.17M | -97.5% | +0.0% |
| March 31, 2023 | 2.17M | -97.5% | +0.0% |
| December 31, 2022 | 2.17M | -97.5% | -97.5% |
| September 30, 2022 | 86.66M | +0.5% | +0.0% |
| June 30, 2022 | 86.66M | +0.5% | +0.0% |
| March 31, 2022 | 86.65M | +115.5% | +0.0% |
| December 31, 2021 | 86.65M | +115.8% | +0.5% |
- Eloxx Pharmaceuticals, Inc. showed an increase of +35.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2012–2025 period, Eloxx Pharmaceuticals, Inc.’s shares outstanding has declined by 94.9% (from 94.11 million shares to 4.79 million shares).
- The most recent figure is from Eloxx Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: